Two Sigma Investments, LP Brooklyn Immuno Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $0.71 $1,303 - $4,024	5,668 Added 3.64%	161,483 $40,000
Q2 2022 Aug 15, 2022	BUY	$0.48 - $2.03 $56,456 - $238,764	117,618 Added 307.92%	155,815 $81,000
Q1 2022 May 16, 2022	SELL	$1.76 - $4.84 $211,229 - $580,882	-120,017 Reduced 75.86%	38,197 $78,000
Q4 2021 Feb 14, 2022	BUY	$4.17 - $9.79 $576,844 - $1.35 Million	138,332 Added 695.77%	158,214 $660,000
Q3 2021 Nov 15, 2021	BUY	$8.86 - $17.05 $176,154 - $338,988	19,882 New	19,882 $185,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.